FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2954613693> ?p ?o ?g. }

• W2954613693 endingPage "2151" @default.
• W2954613693 startingPage "2138" @default.
• W2954613693 abstract "PET/MRI was introduced for clinical use in 2011 and is now an established modality for the imaging of brain and certain pelvic cancers, whereas clinical use for the imaging of other forms of cancer is not yet widespread. We therefore systematically investigated what has been published on the use of PET/MRI compared to PET/CT in the imaging of cancers outside the brain, focusing on clinical areas of application related to diagnosis, staging and restaging. A systematic search of PubMed/MEDLINE, Embase and the Cochrane Library was performed. Studies evaluating the diagnostic performance of simultaneous PET/MRI in cancer patients were chosen. A total of 3,138 publications were identified and 116 published during the period 2012–2018 were included and were grouped according to the major cancer forms: 13 head and neck (HNC), 9 breast (BC), 21 prostate (PC), 14 gynaecological, 13 gastrointestinal (GIC), and 46 various cancers. Data from studies comparing PET/MRI and PET/CT for staging/restaging suggested the superiority of 18F-FDG PET/MRI for the detection of tumour extension and retropharyngeal lymph node metastases in nasopharyngeal cancer, and for the detection of liver metastases and possibly bone marrow metastases in high-risk BC. FDG PET/MRI tended to be inferior for the detection of lung metastases in HNC and BC. 68Ga-PSMA-11 PET/MRI was superior to PET/CT for the detection of local PC recurrence. FDG PET/MRI was superior to FDG PET/CT for the detection of local tumour invasion in cervical cancer and had higher accuracy for the detection of liver metastases in colorectal cancer. The scoping review methodology resulted in the identification of a huge number of records, of which less than 5% were suitable for inclusion and only a limited number allowed conclusions on the advantages/disadvantages of PET/MRI compared to PET/CT in the oncological setting. There was evidence to support the use of FDG PET/MRI in staging of nasopharyngeal cancer and high-risk BC. Preliminary data indicate the superiority of PET/MRI for the detection of local recurrence in PC, local tumour invasion in cervical cancer, and liver metastases in colorectal cancer. These conclusions are based on small datasets and need to be further explored." @default.
• W2954613693 created "2019-07-12" @default.
• W2954613693 creator A5003427759 @default.
• W2954613693 creator A5003446044 @default.
• W2954613693 creator A5019169779 @default.
• W2954613693 creator A5026820656 @default.
• W2954613693 creator A5035244518 @default.
• W2954613693 creator A5042707365 @default.
• W2954613693 creator A5081378263 @default.
• W2954613693 creator A5087519851 @default.
• W2954613693 creator A5089327941 @default.
• W2954613693 date "2019-07-02" @default.
• W2954613693 modified "2023-10-14" @default.
• W2954613693 title "Hybrid PET/MRI in major cancers: a scoping review" @default.
• W2954613693 cites W1088362176 @default.
• W2954613693 cites W1987306355 @default.
• W2954613693 cites W2016451441 @default.
• W2954613693 cites W2027336127 @default.
• W2954613693 cites W2046858091 @default.
• W2954613693 cites W2068264290 @default.
• W2954613693 cites W2079655364 @default.
• W2954613693 cites W2102318836 @default.
• W2954613693 cites W2105321265 @default.
• W2954613693 cites W2116373844 @default.
• W2954613693 cites W2133811577 @default.
• W2954613693 cites W2156098321 @default.
• W2954613693 cites W2158176512 @default.
• W2954613693 cites W2195657520 @default.
• W2954613693 cites W2207385770 @default.
• W2954613693 cites W2207809548 @default.
• W2954613693 cites W2209603382 @default.
• W2954613693 cites W2231106641 @default.
• W2954613693 cites W2243379852 @default.
• W2954613693 cites W2256628135 @default.
• W2954613693 cites W2319241414 @default.
• W2954613693 cites W2325582166 @default.
• W2954613693 cites W2514692614 @default.
• W2954613693 cites W2554936577 @default.
• W2954613693 cites W2567705791 @default.
• W2954613693 cites W2590668990 @default.
• W2954613693 cites W2609365034 @default.
• W2954613693 cites W2615677269 @default.
• W2954613693 cites W2724221442 @default.
• W2954613693 cites W2735959257 @default.
• W2954613693 cites W2742300299 @default.
• W2954613693 cites W2789868025 @default.
• W2954613693 cites W2791408578 @default.
• W2954613693 cites W2808583705 @default.
• W2954613693 cites W2891378911 @default.
• W2954613693 cites W2901669506 @default.
• W2954613693 cites W2991792334 @default.
• W2954613693 doi "https://doi.org/10.1007/s00259-019-04402-8" @default.
• W2954613693 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31267161" @default.
• W2954613693 hasPublicationYear "2019" @default.
• W2954613693 type Work @default.
• W2954613693 sameAs 2954613693 @default.
• W2954613693 citedByCount "31" @default.
• W2954613693 countsByYear W29546136932020 @default.
• W2954613693 countsByYear W29546136932021 @default.
• W2954613693 countsByYear W29546136932022 @default.
• W2954613693 countsByYear W29546136932023 @default.
• W2954613693 crossrefType "journal-article" @default.
• W2954613693 hasAuthorship W2954613693A5003427759 @default.
• W2954613693 hasAuthorship W2954613693A5003446044 @default.
• W2954613693 hasAuthorship W2954613693A5019169779 @default.
• W2954613693 hasAuthorship W2954613693A5026820656 @default.
• W2954613693 hasAuthorship W2954613693A5035244518 @default.
• W2954613693 hasAuthorship W2954613693A5042707365 @default.
• W2954613693 hasAuthorship W2954613693A5081378263 @default.
• W2954613693 hasAuthorship W2954613693A5087519851 @default.
• W2954613693 hasAuthorship W2954613693A5089327941 @default.
• W2954613693 hasBestOaLocation W29546136932 @default.
• W2954613693 hasConcept C121608353 @default.
• W2954613693 hasConcept C126322002 @default.
• W2954613693 hasConcept C126838900 @default.
• W2954613693 hasConcept C142724271 @default.
• W2954613693 hasConcept C143409427 @default.
• W2954613693 hasConcept C143998085 @default.
• W2954613693 hasConcept C2775842073 @default.
• W2954613693 hasConcept C2776256026 @default.
• W2954613693 hasConcept C2778220009 @default.
• W2954613693 hasConcept C2780192828 @default.
• W2954613693 hasConcept C2780849966 @default.
• W2954613693 hasConcept C2989005 @default.
• W2954613693 hasConcept C530470458 @default.
• W2954613693 hasConcept C71924100 @default.
• W2954613693 hasConceptScore W2954613693C121608353 @default.
• W2954613693 hasConceptScore W2954613693C126322002 @default.
• W2954613693 hasConceptScore W2954613693C126838900 @default.
• W2954613693 hasConceptScore W2954613693C142724271 @default.
• W2954613693 hasConceptScore W2954613693C143409427 @default.
• W2954613693 hasConceptScore W2954613693C143998085 @default.
• W2954613693 hasConceptScore W2954613693C2775842073 @default.
• W2954613693 hasConceptScore W2954613693C2776256026 @default.
• W2954613693 hasConceptScore W2954613693C2778220009 @default.
• W2954613693 hasConceptScore W2954613693C2780192828 @default.
• W2954613693 hasConceptScore W2954613693C2780849966 @default.
• W2954613693 hasConceptScore W2954613693C2989005 @default.

• next